Cargando…
Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
The host innate immune system develops various strategies to antagonize virus infection, and the pathogen subverts or evades host innate immunity for self-replication. In the present study, we discovered that Avibirnavirus infectious bursal disease virus (IBDV) VP3 protein significantly inhibits MDA...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125067/ https://www.ncbi.nlm.nih.gov/pubmed/33975961 http://dx.doi.org/10.1128/mSystems.00016-21 |
_version_ | 1783693391305900032 |
---|---|
author | Deng, Tingjuan Hu, Boli Wang, Xingbo Lin, Lulu Zhou, Jianwei Xu, Yuting Yan, Yan Zheng, Xiaojuan Zhou, Jiyong |
author_facet | Deng, Tingjuan Hu, Boli Wang, Xingbo Lin, Lulu Zhou, Jianwei Xu, Yuting Yan, Yan Zheng, Xiaojuan Zhou, Jiyong |
author_sort | Deng, Tingjuan |
collection | PubMed |
description | The host innate immune system develops various strategies to antagonize virus infection, and the pathogen subverts or evades host innate immunity for self-replication. In the present study, we discovered that Avibirnavirus infectious bursal disease virus (IBDV) VP3 protein significantly inhibits MDA5-induced beta interferon (IFN-β) expression by blocking IRF3 activation. Binding domain mapping showed that the CC1 domain of VP3 and the residue lysine-155 of tumor necrosis factor receptor-associated factor 3 (TRAF3) are essential for the interaction. Furthermore, we found that the CC1 domain was required for VP3 to downregulate MDA5-mediated IFN-β production. A ubiquitination assay showed that lysine-155 of TRAF3 was the critical residue for K33-linked polyubiquitination, which contributes to the formation of a TRAF3-TBK1 complex. Subsequently, we revealed that VP3 blocked TRAF3-TBK1 complex formation through reducing K33-linked polyubiquitination of lysine-155 on TRAF3. Taken together, our data reveal that VP3 inhibits MDA5-dependent IRF3-mediated signaling via blocking TRAF3-TBK1 complex formation, which improves our understanding of the interplay between RNA virus infection and the innate host antiviral immune response. IMPORTANCE Type I interferon plays a critical role in the host response against virus infection, including Avibirnavirus. However, many viruses have developed multiple strategies to antagonize the innate host antiviral immune response during coevolution with the host. In this study, we first identified that K33-linked polyubiquitination of lysine-155 of TRAF3 enhances the interaction with TBK1, which positively regulates the host IFN immune response. Meanwhile, we discovered that the interaction of the CC1 domain of the Avibirnavirus VP3 protein and the residue lysine-155 of TRAF3 reduced the K33-linked polyubiquitination of TRAF3 and blocked the formation of the TRAF3-TBK1 complex, which contributed to the downregulation of host IFN signaling, supporting viral replication. |
format | Online Article Text |
id | pubmed-8125067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-81250672021-06-09 Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation Deng, Tingjuan Hu, Boli Wang, Xingbo Lin, Lulu Zhou, Jianwei Xu, Yuting Yan, Yan Zheng, Xiaojuan Zhou, Jiyong mSystems Research Article The host innate immune system develops various strategies to antagonize virus infection, and the pathogen subverts or evades host innate immunity for self-replication. In the present study, we discovered that Avibirnavirus infectious bursal disease virus (IBDV) VP3 protein significantly inhibits MDA5-induced beta interferon (IFN-β) expression by blocking IRF3 activation. Binding domain mapping showed that the CC1 domain of VP3 and the residue lysine-155 of tumor necrosis factor receptor-associated factor 3 (TRAF3) are essential for the interaction. Furthermore, we found that the CC1 domain was required for VP3 to downregulate MDA5-mediated IFN-β production. A ubiquitination assay showed that lysine-155 of TRAF3 was the critical residue for K33-linked polyubiquitination, which contributes to the formation of a TRAF3-TBK1 complex. Subsequently, we revealed that VP3 blocked TRAF3-TBK1 complex formation through reducing K33-linked polyubiquitination of lysine-155 on TRAF3. Taken together, our data reveal that VP3 inhibits MDA5-dependent IRF3-mediated signaling via blocking TRAF3-TBK1 complex formation, which improves our understanding of the interplay between RNA virus infection and the innate host antiviral immune response. IMPORTANCE Type I interferon plays a critical role in the host response against virus infection, including Avibirnavirus. However, many viruses have developed multiple strategies to antagonize the innate host antiviral immune response during coevolution with the host. In this study, we first identified that K33-linked polyubiquitination of lysine-155 of TRAF3 enhances the interaction with TBK1, which positively regulates the host IFN immune response. Meanwhile, we discovered that the interaction of the CC1 domain of the Avibirnavirus VP3 protein and the residue lysine-155 of TRAF3 reduced the K33-linked polyubiquitination of TRAF3 and blocked the formation of the TRAF3-TBK1 complex, which contributed to the downregulation of host IFN signaling, supporting viral replication. American Society for Microbiology 2021-05-11 /pmc/articles/PMC8125067/ /pubmed/33975961 http://dx.doi.org/10.1128/mSystems.00016-21 Text en Copyright © 2021 Deng et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Deng, Tingjuan Hu, Boli Wang, Xingbo Lin, Lulu Zhou, Jianwei Xu, Yuting Yan, Yan Zheng, Xiaojuan Zhou, Jiyong Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation |
title | Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation |
title_full | Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation |
title_fullStr | Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation |
title_full_unstemmed | Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation |
title_short | Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation |
title_sort | inhibition of antiviral innate immunity by avibirnavirus vp3 via blocking tbk1-traf3 complex formation and irf3 activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125067/ https://www.ncbi.nlm.nih.gov/pubmed/33975961 http://dx.doi.org/10.1128/mSystems.00016-21 |
work_keys_str_mv | AT dengtingjuan inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT huboli inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT wangxingbo inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT linlulu inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT zhoujianwei inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT xuyuting inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT yanyan inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT zhengxiaojuan inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation AT zhoujiyong inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation |